Dr. Jonathan Goldman has 35 years of experience in healthcare as a practicing cardiologist, corporate executive, private equity operator, and investor. He is the former CEO of Aptuit and Abzena, and current CEO at Clinical ink. all high-growth private equity-backed global companies in the pharmaceutical services space. He currently serves as a board member at Avalo Therapeutics , a NASDAQ listed biotechnology company. He was previously the Global Head of Sales at ICON plc, a large public clinical CRO and served as cardiology faculty at the University of California San Francisco.

He holds a Bachelor of Science, a Bachelor of Medicine and Surgery with Distinction, and a Doctorate in Medicine from the University of London. Additionally, he earned Master of Business Administration degrees from the University of California Berkeley and Columbia University.